Treatment of persistent congenital chylothoraxwith intrapleural injection of sapylin in infants
Test the therapeutic efficacy of Sapylin in resolving persistent Congenital Chylothorax (CC) in four infants who failed to respond to conservative medical therapy including Erythromycin and/or Octreotide management. All cases were cured and have no adverse reactions during follow-up. The result shows Sapylin is effective in reducing chylous production.
How to cite this:Hua QW, Lin ZY, Hu XT, Zhao QF. Treatment of persistent congenital chylothorax with intrapleural injection of sapylin in infants. Pak J Med Sci. 2016;32(5):1305-1308. doi: http://dx.doi.org/10.12669/pjms.325.10142
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- There are currently no refbacks.